farmasino elagolix sodium 832720 36 2

Elagolix Sodium (832720-36-2) Product Overview Elagolix sodium (ABT-620) is a small molecule, orally active gonadotropin-releasing hormone (GnRH) receptor antagonist designed to provide effective treatment for endometriosis symptoms. Suppresses estradiol (E2) concentrations in a dose-dependent manner First orally available GnRH antagonist on the market Offers advantages over injectable peptide-based treatments Serves an estimated patient population of over 170 million women